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Aims and method True Colours is an automated symptom monitoring programme
used by National Health Service psychiatric services. This study explored whether
patients with unipolar treatment-resistant depression (TRD) found this a useful
addition to their treatment regimes. Semi-structured qualitative interviews were
conducted with 21 patients with TRD, who had engaged in True Colours monitoring
as part of the Lithium versus Quetiapine in Depression study. A thematic analysis
was used to assess participant experiences of the system.
Results Six main themes emerged from the data, the most notable indicating that
mood monitoring increased patients’ insight into their disorder, but that subsequent
behaviour change was absent.
Clinical implications Patients with TRD can benefit from mood monitoring via True
Colours, making it a worthwhile addition to treatment. Further development of such
systems and additional support may be required for patients with TRD to experience
further benefits as reported by other patient groups.
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Patients with treatment-resistant depression (TRD) can
experience a more chronic and severe course of illness.1
These outcomes could be improved by online mood monitor-
ing to facilitate treatment personalisation, and the evaluation
of treatment efficacy.2–4 True Colours is an automated mon-
itoring system developed by clinicians and currently used by
psychiatric services in Oxford Health National Health Service
(NHS) Foundation Trust, as well as by clinical trials across
the country. Patients in Oxford Health are provided with
access to True Colours by their clinical team at their or
their clinicians request, whereas clinical trial teams can use
the system to monitor participants and collect relevant
outcome data. True Colours is also available via the Bipolar
Disorder Research Network to patients with a diagnosis of
bipolar disorder living in the UK.5 The system allows patients
to self-monitor and self-manage symptoms6 by prompting
them to complete personalised questionnaire assessments
according to the time, frequency and mode of interaction
selected. Patient responses are stored and displayed graphic-
ally through the interface, and are also made available to the
patient’s clinician or research team.
Adherence rates in patients with bipolar disorder are
between 75 and 100%,7,8 and qualitative assessments indi-
cated that patients with bipolar disorder find the system
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easy to use and a positive contributor to their clinical care
and self-management.9 Comments on the flexibility of the
system led to the development of a personalised question-
naire feature, which allows patients to add questions to
their schedule.10 However, although the system is routinely
used by patients with unipolar TRD, it is not clear whether
they similarly benefit. Establishing the experience of this
patient group is essential to maximising the clinical utility
of this and other mood monitoring systems. This study
aimed to qualitatively assess the perspectives of patients
with unipolar TRD who used True Colours as part of the
Lithium versus Quetiapine in Depression (LQD) study.11
Method
Ethical approval was obtained from Cambridge South
Research Ethics Committee (approval number 16/EE/
0318). All participants provided written informed consent.
This study has been carried out in accordance with the
Declaration of Helsinki.
Participants
LQD participants were invited to take part in this study
between March 2017 and March 2018. This was a conveni-
ence sample, meaning that LQD participants attending an
8, 26 or 52 week follow-up assessment in that period were
given the opportunity to participate in this additional
study at the relevant follow-up assessment, conducted at a
clinical research facility. Repeat interviews were not con-
ducted. The full methodology of LQD has been reported.11
In brief, adult patients meeting the criteria for TRD were
randomised to receive lithium or quetiapine augmentation
and followed up over 12 months. As part of the study, parti-
cipants were asked to complete two questionnaires weekly
via True Colours to collect primary outcome data: the
Quick Inventory of Depressive Symptomatology (QIDS-
SR)12 and Work and Social Adjustment Scale (WSAS).13
Study-specific questions regarding medication were included
to track dosage and adherence.
Interview procedures
Participants took part in semi-structured interviews
conducted by a researcher (full interview schedule is in
the supplementary material, available at https://doi.org/10.
1192/bjb.2019.92). Researchers were predominantly female
and held a relevant undergraduate or master’s degree. L.M.
conducted training with all interviewers. Typically, the
researchers had an existing relationship with the intervie-
wees having conducted their prior LQD assessments.
Interviews ceased once data saturation was reached, mean-
ing no new emergent themes were being identified by the
collection of additional data.14
Data analysis
Interviews were audio-recorded, transcribed verbatim and
checked by another researcher. All identifiable information
was removed, and participants were assigned a code for
reference.
A thematic analysis was conducted – a widely used
method for identifying, analysing and reporting patterns
within data – with steps recommended by Braun and
Clarke.15 This included actively reading the entire data-set
several times, systematically identifying and coding for key
features, analysing codes and combining them to form
broader themes. Themes were them reviewed and refined
to ensure that they were appropriate in relation to the
coded extracts, as well as the entire data-set. This led to
the removal of some themes (e.g. owing to lack of supporting
data), and the collapsing of others into one, with additional
subthemes. Finally, themes were appropriately named, and
evidence included for each in the present report. This
approach is inductive (bottom-up), meaning the themes
identified were data driven.16 Two researchers (E.I. and B.V.)
conducted analyses independently, and discrepancies in
the identified themes were discussed with L.M. and R.W.T.
until resolved by consensus. The second rater (B.V.) did
not conduct any qualitative interviews, minimising any
potential bias.
Results
A total of 26 individuals were invited to take part; 21 parti-
cipated and five declined, primarily owing to fatigue (see
Tables 1 and 2 for demographics and clinical characteristics).
We generated 81 initial codes from the qualitative data and
combined them to form six themes (see Table 3). Duration
of interviews ranged from 3 to 17min (mean 6.9 ± 3.3).
Table 1 Demographic characteristics of participants
(n = 21)
Characteristic









Education level, n (%)
Primary education or less 1 (5)
Secondary education 3 (14)
College-level education or equivalent 5 (23)
Degree-level education/diploma 5 (23)
Postgraduate degree 7 (32)
NHS trust, n (%)
South London & Maudsley NHS Foundation Trust 13 (62)
Northumberland, Tyne and Wear NHS Foundation
Trust
3 (14)
Oxford Health NHS Foundation Trust 5 (24)
Percentages may not add up to 100 owing to rounding.
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Insight
Anticipated insight (before using True Colours)
Participants frequently described how True Colours enabled
greater understanding of illness. This outcome was antici-
pated by almost half of the participants upon hearing
about the system.
‘I thought that, you know, it would give us something to
go by, some kind of guideline, on, you know, where I am
with my moods, or my behaviour and my sleeping and so
forth’ (P6).
‘I had an expectation that it may be useful that you would
have some form of er. . .information that you know, whether
you’re progressing or whether you’re not in relation to your
treatment, and in relation to how your illness is affecting
you’ (P7).
Experienced insight
Regardless of whether it had been anticipated, 18 participants
found that symptommonitoring enabled reflection. For some,
viewing changes over time helped put their mood into per-
spective, particularly when feeling low. The process of com-
pleting questionnaire(s) appeared to play a key role in
increasing awareness, and how mood linked to symptoms
such as increased weight. Although many participants viewed
this awareness positively, and one person reported a positive
effect on their mood, a small number did not find it beneficial.
‘It’s allowed me to monitor things ‘cause obviously certain
weeks can be worse than others or better than others. . .so
yeah it’s been quite useful’ (P1)
‘Rather thanthinking “I’mreallydepressed, I’mreallydepressed,
I’m really depressed”, I’m able to kind of say “the score’s the
same” and actually, it’s. . .your mood is the same. . .it’s, you
know, in your head that things are worse’ (P10).
‘You’re looking at that [graphs] saying “Eee God I’m depressed”
and it makes you feel even worse’ (P7).
Envisioned insight
This subtheme refers to insight that could be gained through
continued use of True Colours. Six participants felt this
could be possible, several of whom had not experienced sig-
nificant mood fluctuations when using True Colours, but felt
the graphs could help detect future changes. Others, who
had not used the graphs discussed how they could offer
future insight into mood patterns.
‘I would have thought that if I did use it [graphs], yes it would
be useful. . .’’cause it would, you know, be able to tell me
where the fluctuations are. With this said, I will make,
um. . .endeavour to have a look in the next couple of weeks’
(P6).
‘I don’t think it was originally that it would be particularly
useful until I actually see how the changes are mapped on
the graphs and stuff like that. So, the more interested I am,
I think the more useful it’ll be’ (P8).
‘I mean its early days but umm. . .but I think it [the graphs]
will be useful in the future’ (P20).
Absence of behaviour change
True Colours did not appear to affect the way in which most
participants (n = 19) managed their depression. Because of
the lack of changes reported, no subthemes were identified
for this category. Participants recognised that the system
could provide them with information, but did not see how
this could translate to illness management.
‘Probably er. . .not err. . .not as much as manage it but be
aware of it’ (P21).
‘No. Just. . .just it’s informative. It doesn’t change my life-
style’ (P18).
Improved clinical care
Using feedback during clinical appointments
Seven participants suggested the feedback provided via True
Colours (i.e. graphs) could improve the efficiency of time
spent with healthcare providers.
Table 2 Clinical characteristics of participants (n = 21)
Characteristic
Total HRSD score,a mean (s.d.) 22.3 (5.8)
Number of past episodes of depression, mean (s.d.) 4.1 (4.6)






Length of current episode in years, mean (s.d.) 8.4 (11.2)




Overall mean % adherence to weekly True Colours
data submission (s.d.)
72 (35)
HRSD, Hamilton Rating Scale for Depression.
a. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;
23: 56–62.
Percentages may not add up to 100 owing to rounding.
Table 3 Themes and subthemes
Theme Subthemes
Insight Anticipated insight (before using True
Colours)
Experienced insight
Envisaged insight (gained through




Improved clinical care Using feedback during clinical
appointments





Discrepancy between experience and
questionnaire response options
Ambiguity and repetitiveness of questions
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‘True Colours would be a way of keeping track of everything
and also it would give me a visual representation to show
medical professionals as opposed to just going well. . . I had
a bad week 2 weeks ago. I can actually show them what
happened as opposed to trying to remember it’ (P1).
‘I think for a professional that is dealing with your, or
supporting you, I think that information I think may be use-
ful’ (P7).
Valuing access to human support
For four participants, the awareness that they could be mon-
itored by a professional who would understand their difficul-
ties was a source of reassurance.
‘When I had a bad week then I emailed Tr. . .the. . .the link on
True Colours. . .to say look, this is happening and. . .and it did
help to know that somebody else understood what I was
going through rather than me saying to somebody I’m feeling
a bit. . .crap this week and they’re just - oh. . .pooh poohing it
really’ (P4).
‘Knowing that there is somebody out there that’s monitoring
me. . .which is nice’ (P3).
Prioritisation
Organising time
Seven participants admitted that they struggled to schedule
time for True Colours and often forgot to complete
questionnaires.
‘There just isn’t enough time in my day to do it’ (P5).
‘Sometimes I’ll be working or something and I’ll forget to do
it’ (P1).
‘The only times I’ve kind of not done it is when I’ve kind of
been really busy throughout the day’ (P10).
Motivation
Even setting aside the issue of time, over half of participants
indicated that because of a lack of interest, not prioritising
or viewing True Colours as useful and/or an inertia (related
to their illness), it was difficult to engage consistently.
‘It depends where I am mentally on that particular day.
Um. . .sometimes, do you know, I won’t, I won’t, won’t be
able to get out of bed to brush my teeth. And to be able, do
you know, look onto your phone and fill out questionnaires,
it’s nigh on impossible’ (P6).
‘While I was sat there trying to psychoanalyse myself through
True Colours I feel as though I could be doing something,
achieving something that will possibly help me through this
journey I am on’ (P5).
‘I think that you can spend too much time thinking about like
erm being depressed, or the causes of depression, or how
you’re feeling, rather than living your life’ (P8).
Categorisation concerns
Discrepancy between experience and questionnaire response
options
Seven participants raised concerns regarding their ability to
accurately summarise symptoms over the past week when
there had been significant variability. They also felt there
were not sufficient options to express experiences.
‘I couldn’t categorise myself because my days are so. . .at the
moment so mixed up’ (P5).
‘Umm. . .sometimes it’s hard to put how you’ve been feeling
or. . .kind of. . .getting an average. . .having a discrete box can
be hard when you kind of want to do “well it’s that point 5
or. . .”. . .ideally I’d say “it’s just one between two points”
rather than. . .a specific number’ (P15).
Ambiguity and repetitiveness of questions
Comments were also made regarding the wording of some
questions, and how they were either difficult to understand,
or similar to others. This left a small number of participants
feeling unsure about how to respond.
‘There was one question on there which. . .um. . .seemed a
bit. . .could be misconstrued’ (P2).
‘Yeah, yeah, like it’s sometimes you feel it’s getting
rep. . .uh. . .repeating itself all the time’ (P3).
Interface features
Positive experiences
Positive features relating to the interface were identified.
Just over half of participants described the ease of logging
on and completing questionnaire(s), and five participants
commented on the usefulness of personalised weekly
prompts.
‘Yeah. . .it’s really easy. . .it’s all. . . it’s all laid out there for you
so you just umm you know. . .tick whatever it is’ (P20).
‘I’ve had experienced nothing technical wise about it, nah, it’s
always been quite problem free’ (P7).
‘I think like it’s good that there’s a reminder. . .and that
I could choose when it was. Umm. . .because it’s like quite a
convenient time for me just like in the evening to go on my
phone, and it’s quite quick to do the questionnaires. . .and
like you can choose when that comes which I think’s really
good’ (P19).
Challenges
A variety of challenges relating to True Colours were simi-
larly identified. Although participants were aware they
could access response graphs, not all were using this feature.
Four found the graphs difficult to interpret, and therefore
not useful, and one commented on the lack of graphs for per-
sonalised questions. Further, 13 participants reported tech-
nical and interface issues, which affected their ability to
complete questionnaire(s) and/or access feedback.
‘Like the symptom graph I don’t quite get, and I don’t quite
understand how it works. . .erm. . .’cause I just see it as a load
of blobs’ (P10).
‘I’d added like other questions just like for myself on there,
but I wasn’t able to see those on the graph, I could only
see the study ones’ (P19).
‘It’s not as good on the phone ‘cause you can’t see it as prop-
erly as well as you can on the computer’ (P3).
‘I can’t log in, I don’t try anymore’ (P14).
Finally, two participants felt that human contact, rather
than a technology-based approach, would more likely facili-
tate an open and honest sharing of information and aid
recovery.
‘I think the only way you get to know things is by talking. . .I
know that’s not um. . .possible. . .but for people like me with
my problem at my age we are not used to. . .um. . .baring
our soul on a computer’ (P5).
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‘I could fill a questionnaire and I could lie through my teeth,
but I think you soon get caught out if you’re sitting with a
human being’ (P8).
Suggestions for improvement
Six participants volunteered information about ways in
which the interface could be improved, including simplifica-
tion of the questionnaire(s), and further personalisation
options such as adding notes to questionnaire responses.
‘I still feel it can be simplified, to make it, make it a bit more
user friendly. Realising that, you know, people using it may
have various mental health issues, that might require, a bit
more basis yes or no’ (P7).
‘Maybe if you could like. . . I don’t know, like write notes at bot-
tom or something, or like just for your own reference’ (P20).
‘Perhaps some way of changing the size of the text very easily
would help, especially for people who aren’t very computer lit-
erate’ (P15).
Discussion
This study explored whether patients with unipolar TRD
found True Colours, an online mood monitoring system
used by NHS services, a useful addition to their treatment
regimens. Our key findings were that mood monitoring
enabled participants to feel that they had greater insight
into their disorder, regardless of whether this was anticipated
before use, but participants felt that their use of True Colours
did not result in behaviour change. Many participants viewed
their increased insight positively; but for some, spending time
evaluating their symptoms was thought to contribute to a
deterioration in mood. This aligns with the suggestion that
the ability to identify and characterise one’s mood state can
predict positive affect, but a tendency to frequently scrutinise
one’s mood can predict negative affect and rumination.17
For most participants the perceived increase in insight
was not associated with subsequent behaviour change.
Neither completing the questionnaire(s) nor viewing the
online graphs, which depicted their responses over time,
led participants to make connections between patterns in
their illness and their lifestyle choices. This is in contrast
with research in patients with bipolar disorder, whereby
monitoring via True Colours and other automated systems
was associated with change in behaviour/improved self-
management.8,9 This may be owing to the differing nature
of TRD, which is not characterised by the same cyclic
mood changes, and patients with unipolar TRD may require
additional support for mood monitoring to inform behaviour
change. It may be that patients with TRD who are undertak-
ing therapies such as behavioural activation could benefit in
this regard. The potentially unique needs of this patient
group highlighted here would clearly benefit from further
qualitative and quantitative research to fully understand
how patients with TRD can benefit from this and other
mood monitoring systems.
Although participants did not use True Colours for self-
management, their responses suggested confidence that the
system could improve clinical care by reducing reliance on
their ability to accurately recall symptoms over time. The pro-
spect of obtaining more contemporaneous data via this and
other mood monitoring systems may improve our understand-
ing of the course of major depressive disorder/TRD, and
support the improvement of outcomes. Another key contribu-
tor to the enhanced clinical care theme was the belief that
True Colours would give patients access to human support.
This perception appeared to provide participants with a sense
of support and reassurance, although this may have been
inflated because of participants’ awareness that their adherence
was monitored by the LQD study team. However, True Colours
does facilitate real-time data sharing with clinicians in standard
clinical practice, although this may not be the case with other
mood monitoring systems, and whether or not data is moni-
tored by a clinician should therefore be made clear to those
who use any online mood monitoring platform.
Three key barriers to mood monitoring via True
Colours were identified. First, participants indicated that
it was difficult to find the time and/or motivation to
engage consistently with the system. However, as dis-
cussed, LQD participants were required to complete two
questionnaires each week as well as study-specific ques-
tions.11 In standard clinical practice, a manageable amount
and frequency of use could be agreed between patient and
clinician. Balancing the need to collect sufficient data
while minimising the burden placed on patients is an
important consideration and likely to be relevant to
other online platforms.
Second, participants raised concerns about their ability
to categorise experiences on standardised questionnaire(s).
For some, there were clear discrepancies between what
they had experienced and available response options.
Others felt uncertain about question wording, reporting
that they were difficult to understand or repetitive.
Although these difficulties relate to the QIDS-SR and
WSAS, and not the monitoring system itself, they indicate
a need for the continued development of simplified self-
report questionnaires to maximise the utility of online
mood monitoring systems while maintaining the validity
and reliability of assessments.
Finally, although participants had a positive experience
with features of the interface (e.g. weekly prompts), a variety
of issues were reported. Several participants chose not to
view the graphs, and the majority of those who did had dif-
ficulty accessing or interpreting feedback. In addition, tech-
nical issues limited the ability of some to interact with the
system. Although these graphical and technical concerns
can be addressed, the finding that a small number of partici-
pants simply preferred human contact indicates that appli-
cations such as True Colours will not be acceptable to all,
as is the case with any intervention.
There are limitations to this study. Convenience sam-
pling was used, and although this is a widely used method
of sampling in qualitative work, it may limit the transferabil-
ity of the results to other settings, particularly as all partici-
pants were selected from a single clinical trial.18 Participants
also varied in how long and to what extent they had used
True Colours, making it difficult for some to comment on
certain features (e.g. the graphs). The content and frequency
of questionnaires was also protocolised according to the
design of the wider clinical trial, although patients did
have the flexibility to add additional questionnaires to
their schedule. Therefore the experience of participants in
the present study may therefore differ from those of patients
using the system to support their usual care, and future
5
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investigation of online mood monitoring in a purely clinical
setting would be of benefit. However, it is noted that the pro-
tocolised questionnaires included in this study are routinely
used in clinical practice.
To our knowledge, this is the first study to explore the
experiences of patients with TRD who use the True
Colours mood monitoring system. Our findings are encour-
aging and suggest the system is reasonably well adhered to
and provides an effective way of capturing outcomes.
However further development is needed to improve the par-
ticipant–system interface, and maximise the clinical utility
of True Colours for this group. Another important step
should be the examination of True Colours use in relation
to treatment outcomes, to assess not only whether patients
perceive the system to be beneficial, but also whether this
translates to an improvement in empirical outcomes.
Although this qualitative study was conducted in a sin-
gle sample taken from a clinical trial, the differences
between the experiences of patients with unipolar TRD
reported here and those of patients with bipolar disorder9
may have wider implications across settings and mood mon-
itoring platforms. It is clear that online tools developed to
support patient care are not ‘one size fits all’, and the experi-
ences and preferences of individual patient groups must be
accounted for during development if such tools are to
provide the benefits intended.
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